The Latest Breaking News from CLX

Is This the Best Rating Metric for You? A Closer Look at Barchart Opinion Rating

The Clorox Company CLX is likely to register top-line growth when it reports fourth-quarter fiscal 2022 earnings on Aug 3. The Zacks Consensus Estimate for quarterly revenues is pegged at $1,856 million, suggesting a rise of around 3% from the prior-year quarter's reported figure.

The stock market has been facing immense volatility lately due to multi-decade high inflation. However, amid high inflationary pressures, consumer defensive stocks tend to remain resilient because of these companies' inelastic demand for products. Consumer defensive stocks The Clorox Company (CLX) and Newell Brands (NWL) look well-positioned to survive the…

Despite the latest federal interest rate increases, the U.S. markets are plumbing record lows amid skyrocketing core inflation. Given the volatile backdrop, we think it could be wise to avoid the stocks of large-cap companies Clorox Company (CLX), Consolidated Edison (ED), Telefónica (TEF), and Avis Budget Group (CAR). These stocks…

Amid rising worries over surging inflation, the Federal Reserve’s hawkish tilt, geopolitical uncertainties, and supply chain crisis, consumer defensive stocks have outperformed the broader market so far. However, not all stocks in this sector are well-positioned to dodge the market’s volatility. For example, lately, Clorox Company (CLX) and Estée Lauder…

Clorox Co (NYSE: CLX) shares are trading lower in Monday's after-hours session after the company reported financial results and cut its full-year earnings forecast.

Monday marks the last chance for investors to receive the next dividend payout from Clorox (NYSE:CLX).

Over the past 3 months, 9 analysts have published their opinion on Clorox (NYSE:CLX) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

The shares of Clorox (CLX) have tumbled more than 14% in price on the company’s worse-than-expected earnings release and diminished full-year guidance. The company is currently grappling with inflationary pressures and supply disruptions, which are negatively impacting its margins. So, with Clorox’s 44-year history of consecutive dividend growth, is the…

Pulled from Benzinga Pro data, Clorox (NYSE:CLX) posted Q2 earnings of $72.00 million, an increase from Q1 of 49.65%. Sales dropped to $1.69 billion, a 6.37% decrease between quarters.

If history is any guide, there may be good fortune ahead for shares of Clorox (NYSE:CLX). A so-called "golden cross" has formed on its chart and, not surprisingly, this could be bullish for the stock.